Stay updated on Adjuvant Nivolumab for Stage II Melanoma Clinical Trial
Sign up to get notified when there's something new on the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page.

Latest updates to the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new history entry 'Revision: v3.3.3' was added, and the items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe History page now shows a new revision entry (v3.3.2) and removes the previous revision (v3.3.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision entry v3.3.1 was added to the Study Record Versions, and the previous v3.2.0 entry was removed.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page no longer displays a government funding/operating status notice that was previously shown as a general site-wide alert. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check67 days agoChange DetectedThe two screenshots show the same version history table with no data added or removed; the differences are limited to layout and styling. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check95 days agoChange Detected- Added a government operating status notice and a link to official sources for NIH Clinical Center status. - Updated version to v3.2.0 and removed reference to v3.1.0.SummaryDifference12%

Stay in the know with updates to Adjuvant Nivolumab for Stage II Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page.